Bristol hires ImClone manufacturing exec
Executive Summary
ImClone Senior VP-Manufacturing Operations & Product Development Joseph Tarnowski will join Bristol-Myers Squibb as senior VP-biologics, manufacturing and process development. ImClone VP-Manufacturing Richard Crowley will take over for Tarnowski as senior VP- biopharmaceutical operations, overseeing the company's biologics manufacturing operations. Crowley joined ImClone in 2000 as assistant VP-manufacturing and was promoted to VP-manufacturing in 2002. Prior to joining ImClone, Crowley held positions at BASF, Genencor International, Eastman Kodak and Monsanto...
You may also be interested in...
Boehringer Ingelheim, Gubra Enter Third Obesity Deal
The independent, family-controlled German group has signed a third R&D pact with Danish biotech Gubra to develop poly-agonist peptides for obesity.
First Phase III Data For Inovio's Immunotherapy VGX-3100 Encouraging In Cervical Dysplasia
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.
What’s Next? Five Things To Look Out For In March
In the month ahead, a key ANDA approval could come for Viatris, while additional competition to Gilead Sciences’ Truvada for PrEP is on the way in the US following Teva and Amneal’s launches.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: